Cargando…

Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation

Wet media milling, coupled with spay drying, is a commonly proposed formulation strategy for the production and solidification of nanosuspensions in order to overcome the solubility barrier of BCS Class II substances. However, the application of mechanically and thermally intensive processes is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouranidis, Andreas, Gkampelis, Nikos, Vardaka, Elisavet, Karagianni, Anna, Tsiptsios, Dimitrios, Nikolakakis, Ioannis, Kachrimanis, Kyriakos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602516/
https://www.ncbi.nlm.nih.gov/pubmed/33066680
http://dx.doi.org/10.3390/pharmaceutics12100969
_version_ 1783603699300433920
author Ouranidis, Andreas
Gkampelis, Nikos
Vardaka, Elisavet
Karagianni, Anna
Tsiptsios, Dimitrios
Nikolakakis, Ioannis
Kachrimanis, Kyriakos
author_facet Ouranidis, Andreas
Gkampelis, Nikos
Vardaka, Elisavet
Karagianni, Anna
Tsiptsios, Dimitrios
Nikolakakis, Ioannis
Kachrimanis, Kyriakos
author_sort Ouranidis, Andreas
collection PubMed
description Wet media milling, coupled with spay drying, is a commonly proposed formulation strategy for the production and solidification of nanosuspensions in order to overcome the solubility barrier of BCS Class II substances. However, the application of mechanically and thermally intensive processes is not straightforward in the cases of ductile and/or low melting point substances that may additionally be susceptible to eutectic formation. Using ibuprofen (IBU) as a model drug with non-favorable mechanical and melting properties, we attempt to rationalize nanocrystal formulation and manufacturing in an integrated approach by implementing Quality by Design (QbD) methodology, particle informatics techniques and computationally assisted process design. Wet media milling was performed in the presence of different stabilizers and co-milling agents, and the nanosuspensions were solidified by spray-drying. The effects of key process parameters (bead diameter, milling time and rotational speed) and formulation variables (stabilizer type and drug/stabilizer ratio) on the critical quality attributes (CQAs), i.e., Z-average size, polydispersity index (PDI), ζ-potential and redispersibility of spray-dried nanosuspensions were evaluated, while possible correlations between IBU free surface energy and stabilizer effectiveness were studied. The fracture mechanism and surface stabilization of IBU were investigated by computer simulation of the molecular interactions at the crystal lattice level. As a further step, process design accounting for mass-energy balances and predictive thermodynamic models were constructed to scale-up and optimize the design space. Contemplating several limitations, our multilevel approach offers insights on the mechanistic pathway applicable to the substances featuring thermosensitivity and eutectic tendency.
format Online
Article
Text
id pubmed-7602516
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76025162020-11-01 Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation Ouranidis, Andreas Gkampelis, Nikos Vardaka, Elisavet Karagianni, Anna Tsiptsios, Dimitrios Nikolakakis, Ioannis Kachrimanis, Kyriakos Pharmaceutics Article Wet media milling, coupled with spay drying, is a commonly proposed formulation strategy for the production and solidification of nanosuspensions in order to overcome the solubility barrier of BCS Class II substances. However, the application of mechanically and thermally intensive processes is not straightforward in the cases of ductile and/or low melting point substances that may additionally be susceptible to eutectic formation. Using ibuprofen (IBU) as a model drug with non-favorable mechanical and melting properties, we attempt to rationalize nanocrystal formulation and manufacturing in an integrated approach by implementing Quality by Design (QbD) methodology, particle informatics techniques and computationally assisted process design. Wet media milling was performed in the presence of different stabilizers and co-milling agents, and the nanosuspensions were solidified by spray-drying. The effects of key process parameters (bead diameter, milling time and rotational speed) and formulation variables (stabilizer type and drug/stabilizer ratio) on the critical quality attributes (CQAs), i.e., Z-average size, polydispersity index (PDI), ζ-potential and redispersibility of spray-dried nanosuspensions were evaluated, while possible correlations between IBU free surface energy and stabilizer effectiveness were studied. The fracture mechanism and surface stabilization of IBU were investigated by computer simulation of the molecular interactions at the crystal lattice level. As a further step, process design accounting for mass-energy balances and predictive thermodynamic models were constructed to scale-up and optimize the design space. Contemplating several limitations, our multilevel approach offers insights on the mechanistic pathway applicable to the substances featuring thermosensitivity and eutectic tendency. MDPI 2020-10-14 /pmc/articles/PMC7602516/ /pubmed/33066680 http://dx.doi.org/10.3390/pharmaceutics12100969 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ouranidis, Andreas
Gkampelis, Nikos
Vardaka, Elisavet
Karagianni, Anna
Tsiptsios, Dimitrios
Nikolakakis, Ioannis
Kachrimanis, Kyriakos
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
title Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
title_full Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
title_fullStr Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
title_full_unstemmed Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
title_short Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation
title_sort overcoming the solubility barrier of ibuprofen by the rational process design of a nanocrystal formulation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602516/
https://www.ncbi.nlm.nih.gov/pubmed/33066680
http://dx.doi.org/10.3390/pharmaceutics12100969
work_keys_str_mv AT ouranidisandreas overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation
AT gkampelisnikos overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation
AT vardakaelisavet overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation
AT karagiannianna overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation
AT tsiptsiosdimitrios overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation
AT nikolakakisioannis overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation
AT kachrimaniskyriakos overcomingthesolubilitybarrierofibuprofenbytherationalprocessdesignofananocrystalformulation